slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 231,151-231,180
Pages 10,126
Rows per page 30
Component
231,151-231,180 of 303,780
18
The slide uses a structured comparison of four distinct disease areas to justify the market potential of the EQ101 franchise.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
19
The slide uses western blot data to demonstrate the mechanism of action difference between the competitor (Ruxolitinib) and the company's drug (EQ101).Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
20
Includes clinical trial data and visual evidence of skin improvement.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
21
Equillium | Investor Presentation Deck | 40 slidesEquillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
22
The diagram uses a circular flow/flywheel-like representation to show the disease cycle.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
23
Includes visual longitudinal study (Day 0, 14, 21) and a bar chart comparing PBS, Ruxolitinib, and EQ101.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
24
Data shows higher response rates for 4-mg dose and correlation between baseline severity and treatment efficacy.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
25
The slide uses a combination of qualitative physician sentiment and quantitative survey data to frame the problem of safety in current standard-of-care treatments.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Includes definition of SALT score in footer.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
27
Equillium | Investor Presentation Deck | 40 slidesEquillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
28
The slide uses a four-column process flow to explain the biological rationale, mechanism, preclinical validation, and development status.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
29
The slide uses scientific citations to validate the mechanism of action (IL-21/IL-15) upstream of current therapies.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
30
Uses a clear contrast between patient count and available treatments to frame the market opportunity.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
32
The diagram shows a circular process where inhibitors block IL-15 and IL-21 to prevent damage to gut epithelium.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
33
The slide uses a process-like flow to highlight 'reduce inflammation' as the key target, supported by logos of major pharma companies.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
34
The table categorizes competitors by mechanism (Gluten Modification, Barrier Function, Immune Tolerance, Reduce Inflammation) and lists drug names, targets, and administration routes.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
35
Equillium | Investor Presentation Deck | 40 slidesEquillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
37
The slide uses a timeline-based bar chart to represent the duration of IP protection and exclusivity for various therapeutic assets.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
39
The slide combines clinical development timelines with financial runway projections.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Loop · Why Now1 hit
40
Equillium | Investor Presentation Deck | 40 slidesEquillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
01
Essity | Investor Presentation Deck | 27 slidesEssity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations 1 hit
03
The slide serves as an introduction to the company's mission and scale.Essity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations 1 hit
04
The slide uses a high-contrast pink background with product photography on the right side.Essity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations 1 hit
05
Essity | Investor Presentation Deck | 27 slidesEssity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations Beat · Problem1 hit
06
The slide uses a grid layout to categorize market positions by business unit and includes a callout for the aggregate sales performance.Essity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations 1 hit
07
Essity | Investor Presentation Deck | 27 slidesEssity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations Beat · Market Size1 hit
08
Essity | Investor Presentation Deck | 27 slidesEssity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations 1 hit
09
Essity | Investor Presentation Deck | 27 slidesEssity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations Loop · Why Now1 hit
10
Essity | Investor Presentation Deck | 27 slidesEssity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations Loop · Zoom In1 hit
11
The slide uses a 2x2 matrix structure to categorize business units: Health & Medical, Professional Hygiene, Consumer Tissue, and Personal Care, grouped under Consumer Goods.Essity | Investor Presentation Deck | 27 slides · Essity
Conference presentation Investor relations 1 hit